
    
      Patients will be identified who are seen in the Johns Hopkins Gastroenterology Clinic, suffer
      from chronic nausea and vomiting that is refractory to both prokinetic and antiemetic
      medications, and are being prescribed olanzapine for treatment of nausea and vomiting.
      Patients who meet criteria will be enrolled and their gastrointestinal symptoms, quality of
      life, and psychological symptoms will be assessed by various questionnaires and followed over
      the course of 3 months.
    
  